Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
1.864
+0.004 (0.22%)
Aug 7, 2026, 12:41 PM EDT - Market open
Annovis Bio Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Annovis Bio stock has a consensus rating of "Strong Buy" and an average price target of $11. The average 1-year stock price forecast is 490.13% higher than the current stock price, while the lowest is $8.00 (+329.18%) and the highest is $17 (+812.02%).
Price Target: $11 (+490.13%)
Analyst Consensus: Strong Buy
Price Target
Chart* Price targets were last updated on Jul 8, 2026.
Analyst Ratings
The average analyst rating for Annovis Bio stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 1 | 1 | 1 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 2 | 2 | 2 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Buy Maintains $8 | Buy | Maintains | $8 | +329.18% | Jul 8, 2026 |
| Roth MKM | Roth MKM | Buy Initiates $8 | Buy | Initiates | $8 | +329.18% | Jul 7, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $17 | Buy | Reiterates | $17 | +812.02% | Apr 14, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.69
from -1.40
EPS Next Year
-0.89
from -1.69
EPS and Forward PE are based on non-GAAP adjusted numbers.